P0CR92 AF NFT

Topoisomerase 1-associated factor 1

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeigvujfajmch6gat7ru5kporufsop25xaiumb4hbin63npbc2rytdu/metadata.json
IPFS of structure file: 
bafybeiht2o5gcnavre7czactyllj3vmcqkheugqyuz2yr7qiiu7x4qyfzu/AF-P0CR92-F1-model_v2.pdb
First NFT owner address (eip-55): 
0xB667305a726a7bBE479c2c6ee2aeD6c760a09F1c
First NFT owner address (bech32): 
genesis1kennqknjdfamu3uu93hw9tkkcas2p8cuq7kzha
Current NFT ID #469429 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1_w

NFT id:
469429
Accession (UniProt):
P0CR92
Name::
Topoisomerase 1-associated factor 1
Experimental Method:
Predicted structure
Sequence source:
Cryptococcus neoformans var. neoformans serotype D (strain JEC21 / ATCC MYA-565)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT P0CR92 research and analysis (ICN3D with VR)

FASTA sequences

>sp|P0CR92|TOF1_CRYNJ Topoisomerase 1-associated factor 1 OS=Cryptococcus neoformans var. neoformans serotype D (strain JEC21 / ATCC MYA-565) OX=214684 GN=TOF1 PE=3 SV=1 MELPDSPPPLDAPSPPHFLDAPQDRWNVFYPAVQTLVNALGGYEEVESPPDSGIFETVYRPGDSVLGVLKDLKKLWRKDDEDDERTVARCMYRAELMKELVAIVVECAERGEWGRKVALVACDLIAALTWPIDVAQELKEIEDEGPVVTDYASLLRAQLEYKALFLKTTKPLKSILSLMVPCLAKPRKDEKDSRIISLGLHVVRNLLAIKDAVAEGTATGEKEEFAHLQSDLITQLDSLTYLQLFLTLASCADKTDLNPFNVIVLDILHLIFRGIKPSELVQDQKRVPIDSLARLLEKEKKQKALNSRVGSTRHSRFGTTITVKTAEQRVVLHRQTAIIENPGKILDMTKRKKAVVAKRMDDLTVFVNLSSDAMVILQSFSKSFLEICYNTFIESILRDIRMERTKIRPSDNIRVFYLSSFFIEYLLLLRHKLLEKGGSRRLEELPLGLVAQIAEMDSVKWLFARLRICWDDKPKAWTELQACIECFTQILLLIDDMSTSTNEEDVEVAEILQHQLYYNYDILDSALAVVREYKNQSIAYLDSIIHFAYVLLRMLEKYSKTKAFMFIRKRKNTHKKRKERQAASQANADREQRKIPEEYGDEGEEAFAPDEDAPSYAEHAFTFQSFEKRFAQEAVVNTLLTYLERFLEFDGPEPMKRVVGLMHRQVIKAHAEGLYFKVSTLIIFRRILDKQHVLPAAPSSRDLITLITYILRKFFKHVEKEPFTLVEALSSKSRGKWKTVGGGSDDDDDEMAGQRGRIKEKMGPVELQFIKKHKFSWSQQMSIAFAIIWGDGHGYLIKWIVEVLEQVLAAKQEIVLTTDGGINGDEDEEDEDGNARVRRFGRPSDEAISKFTQFDLQPEESEQITAVTSNPHFRLMLKLLSFDLPPPPMELDFEEDVSSEELALAREKSDSAWFLPANVLPSDIEASIGALKQYMEEPPTLDDDPKKLLRRKARATRRRRRSPSVESYDSETGEVRPGHQHKKNPRQKRAKKAVETQNYKSAAFIEDSDDEDPEATRRFFENEERLRREMDELAAQGGHPMMERGVKRKRGKKNGKGAISDTPPPSQRGNDRET